| 3CLpro | 3-Chymotrypsin-like protease |
| 5-HpETE | 5(S)-Hydroperoxyeicosatetraenoic acid |
| 5-LOX | 5-Lipoxygenase |
| AA | Arachidonic acid |
| AD | Alzheimer’s disease |
| ADRs | Adverse drug reactions |
| AIF | Apoptosis-inducing factor |
| Akt | Protein kinase B |
| APP | Amyloid-beta precursor protein |
| Aβ | β-Amyloid protein |
| Aβ1–42 | β-Amyloid peptide, amino acids 1 to 42 |
| B-LT | Leukotriene B receptors |
| Bak | Bcl-2 homologous antagonist/killer |
| BAX | Bcl-2-associated X protein |
| BBB | Blood–brain barrier |
| Bcl-2 | B-cell lymphoma 2 |
| CCL2 | C-C motif chemokine 2 |
| CD | Cluster of differentiation |
| cGMP/KATP | Cyclic monophosphate/ATP-sensitive potassium |
| Ciart | Circadian associated repressor of transcription |
| CNS | Central nervous system |
| COVID-19 | SARS-CoV-2 disease |
| cPLA2 | Cytosolic phospholipase A2 |
| CSS | Churg–Strauss Syndrome |
| CTF | C terminal fragment |
| CYP | Cytochrome P450 |
| CysLTR | Cysteinyl leukotrienes receptor (isoforms 1, 2, and 3) |
| CysLTs | Cysteinyl leukotrienes |
| Dbp | D site albumin promoter binding protein |
| DCX | Doublecortin |
| DP | Dipeptidase |
| eIF-2α | Eukaryotic initiation factor-2α |
| Entpd1 | Ectonucleoside triphosphate diphosphohydrolase 1 |
| Erk1/2 | Extracellular signal-regulated kinase 1/2 |
| FAD | Familial early-onset Alzheimer’s disease |
| Fas | Tumour necrosis factor receptor superfamily member 6 |
| FLAP | 5-LOX activating protein |
| GGLT | γ-Glutamyl leukotrienase |
| GGT | γ-Glutamyl transpeptidase |
| GPR17 | G Protein-Coupled Receptor 17 |
| GSH | Glutathione |
| GSSG | Glutathione disulphide |
| HAT | Histone acetyltransferase |
| HD | Hungtinton’s disease |
| HIF-1α | Hypoxia-inducible factor-1 |
| Iba1 | Ionized calcium-binding adaptor molecule 1 |
| IFN-γ | Interferon-γ |
| IL | Interleukin |
| iNOS | Inducible nitric oxide synthase |
| KLF2 | Krüppel-like Factor 2 |
| LDH | Lactate dehydrogenase |
| LPS | Lipopolysaccharide |
| LT | Leukotriene |
| LTA4 | Leukotriene A4 |
| LTA4H | Leukotriene A4 hydrolase |
| LTB4 | Leukotriene B4 |
| LTC4 | Leukotriene C4 |
| LTC4S | Leukotriene C4 synthase |
| LTD4 | Leukotriene D4 |
| LTE4 | Leukotriene E4 |
| MAPK | Mitogen-activated protein kinase |
| MDA | Malondialdehyde |
| MEK | Extracellular signal-regulated kinase kinase |
| Mlec | Malectin protein |
| MOG | Myelin oligodendrocyte glycoprotein |
| Mpro | SARS-CoV-2 Main protease |
| mRNA | Messenger RNA |
| MRP | Multidrug resistance proteins (isoforms 1 and 4) |
| MTK | Montelukast |
| NeuN | Neuronal nuclear protein |
| NF-κB | Nuclear factor kappa B |
| P2Y12 | P2Y purinoceptor 12 |
| p38 MAPK | p38 mitogen-activated protein kinase |
| PCNA | Proliferating cell nuclear antigen |
| PD | Parkinson’s disease |
| PG | Prostaglandin |
| PPAR-α | Peroxisomal proliferator-activated receptor α |
| PPARγ | Proliferator-activated receptor γ |
| PRAS40 | Proline-rich Akt substrate of 40 kDa |
| Psen | Presenilin |
| PTZ | Pentylenetetrazole |
| RdRp | RNA dependent RNA polymerase |
| ROS | Reactive oxygen species |
| SAD | Sporadic late-onset Alzheimer’s disease |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| SMC | Smooth muscle cells |
| SOD | Superoxide dismutase |
| TGF-β1 | Transforming growth factor-beta 1 |
| Tmem119 | Transmembrane protein 119 |
| TNF-α | Tumour necrosis factor α |
| UGT | Glucuronosyltransferase |
| WNK1 | WNK lysine deficient protein kinase 1 |
| Zfp46 | Zinc finger protein 46 |